Page last updated: 2024-08-16

ici 204,219 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ici 204,219 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conklyn, M; Showell, HJ; Watson, JW1
Barnes, PJ; Chung, KF; Kidney, JC; Ridge, SM1

Trials

1 trial(s) available for ici 204,219 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219.
    The American review of respiratory disease, 1993, Volume: 147, Issue:1

    Topics: Adult; Airway Resistance; Bronchoconstriction; Double-Blind Method; Humans; Indoles; Leukocyte Count; Male; Neutrophils; Phenylcarbamates; Platelet Activating Factor; SRS-A; Sulfonamides; Tosyl Compounds

1993

Other Studies

1 other study(ies) available for ici 204,219 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
IgG1-mediated acute pulmonary hypersensitivity response in the guinea pig. Involvement of specific lipid mediators.
    The American review of respiratory disease, 1990, Volume: 142, Issue:5

    Topics: Acute Disease; Animals; Azepines; Bronchoconstriction; Dicarboxylic Acids; Dose-Response Relationship, Drug; Furans; Guinea Pigs; Immunization; Immunoglobulin G; Indoles; Lipids; Lung; Male; Ovalbumin; Phenylcarbamates; Piroxicam; Platelet Activating Factor; Propranolol; Pyrilamine; Respiratory Hypersensitivity; SRS-A; Sulfonamides; Tosyl Compounds; Triazoles

1990